Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tactics for type II diabetes

M C Riddle1

  • 1Division of Endocrinology, Diabetes, Oregon Health Sciences University, Portland, USA.

Endocrinology and Metabolism Clinics of North America
|October 6, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to the Letter to the Editor: Response to Concerns Raised on MRI Surveillance and Clinical Implications of ARIA in Disease Modifying Treatment.

The journal of prevention of Alzheimer's disease·2024
Same author

Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval.

The journal of prevention of Alzheimer's disease·2023
Same author

Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events.

Diabetes & metabolism·2017
Same author

Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial.

Diabetes & metabolism·2017
Same author

Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension).

Diabetes & metabolism·2017
Same author

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).

Diabetes, obesity & metabolism·2015
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Type II diabetes management requires a comprehensive strategy. This includes public health initiatives, primary medical care, and complex individualized treatments for advanced cases.

Area of Science:

  • Endocrinology and Public Health

Background:

  • Type II diabetes is a prevalent chronic disease with significant human and economic impact.
  • Effective management necessitates a multi-faceted approach beyond individual patient care.

Purpose of the Study:

  • To outline a comprehensive, phased strategy for managing Type II diabetes.
  • To delineate distinct approaches for public health, primary medical, and complex management phases.

Main Methods:

  • Public health phase: Focus on identifying susceptible individuals, promoting preventive behaviors, and early screening.
  • Primary management phase: Emphasizes lifestyle interventions, algorithmic prescribing of medications (single and combined), and outcome monitoring.
  • Complex management phase: Addresses patients with complications or inadequate control through individualized treatment plans.

Related Experiment Videos

Main Results:

  • The proposed strategy integrates public health, primary care, and specialized management.
  • Each phase employs specific tactics tailored to disease progression and patient needs.

Conclusions:

  • A structured, multi-phase approach is crucial for effective Type II diabetes management.
  • Integrating public health, primary care, and individualized complex care optimizes patient outcomes.